Clinical Trials · NCT07158021
Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- University of Michigan Rogel Cancer Center
- Enrollment
- 75
- Start date
- Jan 2026
- Locations
- 1 site, United States
- Primary endpoint
- Proportion of participants with ultrasensitive estradiol concentration > 10 pg/ml